- Home
- LBTYK vs PTCT Comparison
LBTYK vs PTCT Comparison
Compare LBTYK & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBTYK | PTCT |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | Bermuda | United States |
| Employees | 6820 | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 5.3B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | LBTYK | PTCT |
|---|---|---|
| Price | $11.23 | $77.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $73.76 |
| AVG Volume (30 Days) | 879.0K | ★ 2.3M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.94 |
| Revenue | ★ $4,770,600,000.00 | $1,779,150,000.00 |
| Revenue This Year | $13.22 | $128.32 |
| Revenue Next Year | $1.67 | N/A |
| P/E Ratio | ★ N/A | $8.64 |
| Revenue Growth | ★ 170.50 | 97.54 |
| 52 Week Low | $9.21 | $35.95 |
| 52 Week High | $14.48 | $87.50 |
Technical Indicators
Market Signals| Indicator | LBTYK | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 54.29 |
| Support Level | $10.88 | $73.03 |
| Resistance Level | $11.49 | $79.03 |
| Average True Range (ATR) | 0.30 | 3.38 |
| MACD | 0.02 | -0.70 |
| Stochastic Oscillator | 62.37 | 29.37 |
Price Performance
Historical ComparisonAbout LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.